newsfilter
← Latest News
GlobeNewswire·

Lexeo Therapeutics to Participate in the Leerink Global Healthcare Conference

NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- Lexeo Therapeutics, Inc. (NASDAQ:LXEO), a clinical stage genetic medicine company dedicated to pioneering novel treatments for cardiovascular diseases, today announced that